Literature DB >> 8290269

Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus.

C E Campbell1, A Huang, A L Gurney, P M Kessler, J A Hewitt, B R Williams.   

Abstract

Transcription of the WT1 locus is restricted, both temporally and spatially, to a subset of epithelial cells in mammalian kidneys and gonads. WT1, one of the two divergent transcripts mapping to this locus encodes a zinc finger protein that is likely a transcriptional regulator. The other transcript, WIT1, encodes a product of unknown function that is subject to alternate splicing in the region immediately 5' of the WT1 gene. Analysis of the 5' end of this locus further revealed the presence of multiple transcriptional start sites for both genes, such that some of the WIT1 transcripts are encoded by the antisense strand of the first exon of WT1. The genomic region surrounding the transcriptional start sites appears to constitute part of a bi-directional promoter based on the ability of a DNA fragment derived from this region to direct expression of a chimeric CAT gene construct in transient transfection assays. Discrete sequences within the region are capable of interaction in vitro with nuclear extracts derived from a variety of rat and mouse tissues. Interestingly, recombinant WT1, representing the product of zinc finger region of the most abundant of the four alternatively spliced transcripts, is also capable of binding to sequences within this region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290269

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog.

Authors:  T Kobayashi; S Urakami; J P Cheadle; R Aspinwall; P Harris; J R Sampson; O Hino
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

Review 2.  Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 3.  The silence RNA keeps: cis mechanisms of RNA mediated epigenetic silencing in mammals.

Authors:  Cristina Tufarelli
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-01-29       Impact factor: 6.237

4.  Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation.

Authors:  Y Ye; B Raychaudhuri; A Gurney; C E Campbell; B R Williams
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

5.  The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotides.

Authors:  S Morelli; D Delia; S Capaccioli; A Quattrone; N Schiavone; A Bevilacqua; S Tomasini; A Nicolin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

6.  Identification of an intronic enhancer that nullifies upstream repression of SPARC gene expression.

Authors:  K Satyamoorthy; S J Samulewicz; L D Thornburg; A Basu; C C Howe
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

Review 7.  Making (anti)sense of non-coding sequence conservation.

Authors:  D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

8.  The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1.

Authors:  Y Chen; B R Williams
Journal:  Gene Expr       Date:  2000

Review 9.  Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes.

Authors:  M Kumar; G G Carmichael
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer.

Authors:  Anthony R Dallosso; Anne L Hancock; Sally Malik; Ashreena Salpekar; Linda King-Underwood; Kathy Pritchard-Jones; Jo Peters; Kim Moorwood; Andrew Ward; Karim T A Malik; Keith W Brown
Journal:  RNA       Date:  2007-10-16       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.